Literature DB >> 19815692

Semiparametric estimation of the average causal effect of treatment on an outcome measured after a postrandomization event, with missing outcome data.

Peter B Gilbert1, Yuying Jin.   

Abstract

In the past decade, several principal stratification-based statistical methods have been developed for testing and estimation of a treatment effect on an outcome measured after a postrandomization event. Two examples are the evaluation of the effect of a cancer treatment on quality of life in subjects who remain alive and the evaluation of the effect of an HIV vaccine on viral load in subjects who acquire HIV infection. However, in general the developed methods have not addressed the issue of missing outcome data, and hence their validity relies on a missing completely at random (MCAR) assumption. Because in many applications the MCAR assumption is untenable, while a missing at random (MAR) assumption is defensible, we extend the semiparametric likelihood sensitivity analysis approach of Gilbert and others (2003) and Jemiai and Rotnitzky (2005) to allow the outcome to be MAR. We combine these methods with the robust likelihood-based method of Little and An (2004) for handling MAR data to provide semiparametric estimation of the average causal effect of treatment on the outcome. The new method, which does not require a monotonicity assumption, is evaluated in a simulation study and is applied to data from the first HIV vaccine efficacy trial.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19815692      PMCID: PMC2800161          DOI: 10.1093/biostatistics/kxp034

Source DB:  PubMed          Journal:  Biostatistics        ISSN: 1465-4644            Impact factor:   5.899


  17 in total

1.  An estimator for treatment comparisons among survivors in randomized trials.

Authors:  Douglas Hayden; Donna K Pauler; David Schoenfeld
Journal:  Biometrics       Date:  2005-03       Impact factor: 2.571

2.  A comparison of eight methods for the dual-endpoint evaluation of efficacy in a proof-of-concept HIV vaccine trial.

Authors:  Devan V Mehrotra; Xiaoming Li; Peter B Gilbert
Journal:  Biometrics       Date:  2006-09       Impact factor: 2.571

3.  Extensions of the penalized spline of propensity prediction method of imputation.

Authors:  Guangyu Zhang; Roderick Little
Journal:  Biometrics       Date:  2008-11-13       Impact factor: 2.571

4.  Comment: Demystifying Double Robustness: A Comparison of Alternative Strategies for Estimating a Population Mean from Incomplete Data.

Authors:  Anastasios A Tsiatis; Marie Davidian
Journal:  Stat Sci       Date:  2007       Impact factor: 2.901

5.  Does Finasteride Affect the Severity of Prostate Cancer? A Causal Sensitivity Analysis.

Authors:  Bryan E Shepherd; Mary W Redman; Donna P Ankerst
Journal:  J Am Stat Assoc       Date:  2008-12-01       Impact factor: 5.033

6.  Reduction in burden of illness: a new efficacy measure for prevention trials.

Authors:  M N Chang; H A Guess; J F Heyse
Journal:  Stat Med       Date:  1994-09-30       Impact factor: 2.373

7.  Placebo-controlled phase 3 trial of a recombinant glycoprotein 120 vaccine to prevent HIV-1 infection.

Authors:  Neil M Flynn; Donald N Forthal; Clayton D Harro; Franklyn N Judson; Kenneth H Mayer; Michael F Para
Journal:  J Infect Dis       Date:  2005-01-27       Impact factor: 5.226

8.  Randomized, double-blind, placebo-controlled efficacy trial of a bivalent recombinant glycoprotein 120 HIV-1 vaccine among injection drug users in Bangkok, Thailand.

Authors:  Punnee Pitisuttithum; Peter Gilbert; Marc Gurwith; William Heyward; Michael Martin; Fritz van Griensven; Dale Hu; Jordan W Tappero; Kachit Choopanya
Journal:  J Infect Dis       Date:  2006-11-03       Impact factor: 5.226

9.  Antiretroviral treatment of adult HIV infection: 2008 recommendations of the International AIDS Society-USA panel.

Authors:  Scott M Hammer; Joseph J Eron; Peter Reiss; Robert T Schooley; Melanie A Thompson; Sharon Walmsley; Pedro Cahn; Margaret A Fischl; Jose M Gatell; Martin S Hirsch; Donna M Jacobsen; Julio S G Montaner; Douglas D Richman; Patrick G Yeni; Paul A Volberding
Journal:  JAMA       Date:  2008-08-06       Impact factor: 56.272

10.  On the analysis of viral load endpoints in HIV vaccine trials.

Authors:  Michael G Hudgens; Antje Hoering; Steven G Self
Journal:  Stat Med       Date:  2003-07-30       Impact factor: 2.373

View more
  4 in total

1.  Commentary on "Principal stratification - a goal or a tool?" by Judea Pearl.

Authors:  Peter B Gilbert; Michael G Hudgens; Julian Wolfson
Journal:  Int J Biostat       Date:  2011-09-20       Impact factor: 0.968

2.  A causal framework for classical statistical estimands in failure-time settings with competing events.

Authors:  Jessica G Young; Mats J Stensrud; Eric J Tchetgen Tchetgen; Miguel A Hernán
Journal:  Stat Med       Date:  2020-01-27       Impact factor: 2.373

3.  Resampling-based methods in single and multiple testing for equality of covariance/correlation matrices.

Authors:  Yang Yang; Victor DeGruttola
Journal:  Int J Biostat       Date:  2012-06-22       Impact factor: 0.968

4.  Identification and estimation of survivor average causal effects.

Authors:  Eric J Tchetgen Tchetgen
Journal:  Stat Med       Date:  2014-05-29       Impact factor: 2.373

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.